Affirm Holdings stock declines amid market weakness
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 18 2024
0mins
Should l Buy AFRM?
Affirm Holdings Inc. shares fell by 7.26% as the stock crossed below its 5-day SMA, reflecting a negative sentiment in the market.
The decline in Affirm's stock price comes amid broader market weakness, with the Nasdaq-100 down 0.37% and the S&P 500 down 0.62%. This sector rotation indicates that investors are reallocating their portfolios in response to the overall market conditions, impacting stocks like Affirm.
Investors should remain cautious as the market sentiment shifts, and monitor any potential changes in analyst ratings that could influence future trading strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AFRM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AFRM
Wall Street analysts forecast AFRM stock price to rise
22 Analyst Rating
17 Buy
5 Hold
0 Sell
Strong Buy
Current: 46.980
Low
65.00
Averages
87.72
High
107.00
Current: 46.980
Low
65.00
Averages
87.72
High
107.00
About AFRM
Affirm Holdings, Inc. provides consumers with an alternative to traditional payment options. The Company is engaged in building a payment network. Its platform comprises three core elements: point-of-sale payment solutions for consumers, merchant commerce solutions, and a consumer-focused app. Its Affirm App and Website provide tailored offers from merchants based on consumers' preferences. Consumers can apply at affirm.com or via the Affirm App and, upon approval, receive a single-use virtual card to use online or in-store. Its Affirm Card allows consumers to link a bank account to pay in full, or apply to pay overtime through the Affirm App. It offers users an in-app post-purchase feature that allows them to instantly apply to convert any eligible debit transaction into an installment loan. Through the Affirm app and in partnership with Cross River Bank, it offers a savings account, with no minimum deposit requirements or fees.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Block Cuts 40% Workforce to Boost Efficiency Amid AI Shift
- Workforce Reduction: Block announced a 40% workforce cut, reducing its headcount from over 10,000 to just under 6,000, indicating a strategic shift in operations influenced by AI tools, which is expected to significantly enhance overall efficiency and profitability.
- Stock Price Reaction: Following the layoff announcement, Block's stock surged approximately 25% in after-hours trading, ultimately closing up 17%, reflecting increased investor confidence in the company's future profitability.
- Earnings Forecast: Block's annual earnings forecast surpassed market expectations, with analysts generally optimistic that AI-driven efficiencies will drive profit growth, leading Morgan Stanley to upgrade its rating to overweight.
- Restructuring Costs: Block anticipates restructuring costs between $450 million and $500 million, primarily front-loaded in the first quarter, with Dorsey opting for a one-time layoff approach to mitigate long-term negative impacts on employee morale.
See More
Paloma Partners Reduces Core Scientific Holdings by 2.5 Million Shares
- Share Reduction Details: According to an SEC filing dated February 17, 2026, Paloma Partners Management Co reduced its holdings in Core Scientific by 2,547,000 shares, with an estimated transaction value of $44.41 million, reflecting a $46.32 million decline in the fund's position value over the quarter, indicating the impact of market volatility on its investment portfolio.
- Current Holdings Analysis: Following the sale, Core Scientific now accounts for only 0.49% of Paloma Partners' reportable U.S. equity assets, with its remaining 185,000 shares valued at $2.69 million at year-end, suggesting a significant reduction in the company's importance within the portfolio.
- Market Performance Overview: As of February 17, 2026, Core Scientific shares were priced at $17.23, reflecting a 39.1% increase over the past year, outperforming the S&P 500 by 25.81 percentage points, demonstrating the company's relative strength in the digital asset market.
- Business Model and Risks: Core Scientific generates revenue through self-mining and equipment hosting, and while its stock price reflects improving crypto sentiment, its profitability remains tied to production efficiency and power costs, necessitating investor attention on key metrics like Bitcoin production efficiency and power cost management.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Overview of Updates: While specific upgrades and downgrades are not detailed, the overall rating changes may prompt investors to reassess their holdings, potentially affecting trading volumes and price fluctuations of the related stocks.
- Expected Market Reaction: Analyst rating adjustments typically trigger immediate market responses, and investors should monitor these changes to timely adjust their investment strategies and capitalize on potential market opportunities.
- Information Access: Investors can access a comprehensive view of rating changes through Benzinga's analyst ratings page, aiding them in making more informed investment decisions.
See More
Market Dynamics and Investment Opportunities Analysis
- Blue Owl Capital Loan Sales: Blue Owl Capital's loan sales are part of a plan to return capital to investors, and while observers have raised 'canary in the coal mine' warnings regarding mispriced private credit loans, the situation does not appear tragic, potentially offering market opportunities.
- Weak U.S. GDP: The preliminary fourth-quarter U.S. GDP growth came in at just 1.4%, significantly below expectations, with the government shutdown likely dragging on growth, leading to market concerns about future economic recovery challenges.
- Texas Roadhouse Strong Performance: Texas Roadhouse shares rose over 3% in early trading, as the market overlooked a weak fourth quarter due to a strong start in Q1, indicating sustained consumer demand for dining despite ongoing beef inflation challenges.
- Klarna's Disappointing Earnings: Klarna reported a wider-than-expected net loss for the quarter, and its fiscal 2026 outlook fell short across key metrics, prompting JPMorgan and UBS to cut their price targets to $20, reflecting market concerns about its future performance.
See More
Bridgewater Associates Acquires Dell and UnitedHealth, Divests AT&T Shares
- Portfolio Changes: Bridgewater Associates made significant adjustments to its investment portfolio in the fourth quarter.
- Exiting Investments: The hedge fund exited its position in a major wireless carrier as part of its strategy.
- Healthcare Holdings: Bridgewater also readjusted its investments in the healthcare sector.
- Market Position: As the largest hedge fund globally by assets under management, these changes reflect its ongoing strategy to optimize performance.
See More
Optimist Fund Declines 8.5% in Q4 2025
- Fund Performance Decline: The Optimist Fund experienced an 8.5% decline in Q4 2025, significantly underperforming the benchmark's 2.0% drop, indicating potential weaknesses in its management strategy that could undermine investor confidence.
- Portfolio Adjustments: During the quarter, the fund exited positions in monday.com (MNDY) and Fiverr International (FVRR), while initiating new investments in Root (ROOT) and Affirm (AFRM), and increasing its stake in DiscoverIE, reflecting a strategic shift towards emerging markets.
- Market Environment Challenges: Fiverr International is grappling with slowing growth, projecting 2026 revenues between $380 million and $420 million, indicating a pivot towards high-value, AI-driven work that may impact its future profitability.
- Cash Flow Status: Despite Affirm's significant increase in free cash flow, its stock continues to decline, raising concerns about future growth prospects, which could adversely affect the overall performance of the Optimist Fund.
See More
Block Cuts 40% Workforce to Boost Efficiency Amid AI Shift
- Workforce Reduction: Block announced a 40% workforce cut, reducing its headcount from over 10,000 to just under 6,000, indicating a strategic shift in operations influenced by AI tools, which is expected to significantly enhance overall efficiency and profitability.
- Stock Price Reaction: Following the layoff announcement, Block's stock surged approximately 25% in after-hours trading, ultimately closing up 17%, reflecting increased investor confidence in the company's future profitability.
- Earnings Forecast: Block's annual earnings forecast surpassed market expectations, with analysts generally optimistic that AI-driven efficiencies will drive profit growth, leading Morgan Stanley to upgrade its rating to overweight.
- Restructuring Costs: Block anticipates restructuring costs between $450 million and $500 million, primarily front-loaded in the first quarter, with Dorsey opting for a one-time layoff approach to mitigate long-term negative impacts on employee morale.
See More
Paloma Partners Reduces Core Scientific Holdings by 2.5 Million Shares
- Share Reduction Details: According to an SEC filing dated February 17, 2026, Paloma Partners Management Co reduced its holdings in Core Scientific by 2,547,000 shares, with an estimated transaction value of $44.41 million, reflecting a $46.32 million decline in the fund's position value over the quarter, indicating the impact of market volatility on its investment portfolio.
- Current Holdings Analysis: Following the sale, Core Scientific now accounts for only 0.49% of Paloma Partners' reportable U.S. equity assets, with its remaining 185,000 shares valued at $2.69 million at year-end, suggesting a significant reduction in the company's importance within the portfolio.
- Market Performance Overview: As of February 17, 2026, Core Scientific shares were priced at $17.23, reflecting a 39.1% increase over the past year, outperforming the S&P 500 by 25.81 percentage points, demonstrating the company's relative strength in the digital asset market.
- Business Model and Risks: Core Scientific generates revenue through self-mining and equipment hosting, and while its stock price reflects improving crypto sentiment, its profitability remains tied to production efficiency and power costs, necessitating investor attention on key metrics like Bitcoin production efficiency and power cost management.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Overview of Updates: While specific upgrades and downgrades are not detailed, the overall rating changes may prompt investors to reassess their holdings, potentially affecting trading volumes and price fluctuations of the related stocks.
- Expected Market Reaction: Analyst rating adjustments typically trigger immediate market responses, and investors should monitor these changes to timely adjust their investment strategies and capitalize on potential market opportunities.
- Information Access: Investors can access a comprehensive view of rating changes through Benzinga's analyst ratings page, aiding them in making more informed investment decisions.
See More
Market Dynamics and Investment Opportunities Analysis
- Blue Owl Capital Loan Sales: Blue Owl Capital's loan sales are part of a plan to return capital to investors, and while observers have raised 'canary in the coal mine' warnings regarding mispriced private credit loans, the situation does not appear tragic, potentially offering market opportunities.
- Weak U.S. GDP: The preliminary fourth-quarter U.S. GDP growth came in at just 1.4%, significantly below expectations, with the government shutdown likely dragging on growth, leading to market concerns about future economic recovery challenges.
- Texas Roadhouse Strong Performance: Texas Roadhouse shares rose over 3% in early trading, as the market overlooked a weak fourth quarter due to a strong start in Q1, indicating sustained consumer demand for dining despite ongoing beef inflation challenges.
- Klarna's Disappointing Earnings: Klarna reported a wider-than-expected net loss for the quarter, and its fiscal 2026 outlook fell short across key metrics, prompting JPMorgan and UBS to cut their price targets to $20, reflecting market concerns about its future performance.
See More
Bridgewater Associates Acquires Dell and UnitedHealth, Divests AT&T Shares
- Portfolio Changes: Bridgewater Associates made significant adjustments to its investment portfolio in the fourth quarter.
- Exiting Investments: The hedge fund exited its position in a major wireless carrier as part of its strategy.
- Healthcare Holdings: Bridgewater also readjusted its investments in the healthcare sector.
- Market Position: As the largest hedge fund globally by assets under management, these changes reflect its ongoing strategy to optimize performance.
See More
Optimist Fund Declines 8.5% in Q4 2025
- Fund Performance Decline: The Optimist Fund experienced an 8.5% decline in Q4 2025, significantly underperforming the benchmark's 2.0% drop, indicating potential weaknesses in its management strategy that could undermine investor confidence.
- Portfolio Adjustments: During the quarter, the fund exited positions in monday.com (MNDY) and Fiverr International (FVRR), while initiating new investments in Root (ROOT) and Affirm (AFRM), and increasing its stake in DiscoverIE, reflecting a strategic shift towards emerging markets.
- Market Environment Challenges: Fiverr International is grappling with slowing growth, projecting 2026 revenues between $380 million and $420 million, indicating a pivot towards high-value, AI-driven work that may impact its future profitability.
- Cash Flow Status: Despite Affirm's significant increase in free cash flow, its stock continues to decline, raising concerns about future growth prospects, which could adversely affect the overall performance of the Optimist Fund.
See More
